髋部骨折关节置换术中骨水泥固定不增加心肺并发症:HIP ATTACK 试验的二次分析
该研究为 HIP ATTACK 随机对照试验的二次分析,纳入 966 例因股骨颈骨折行全髋关节置换或半髋关节置换的患者,其中 61%(593 例)使用骨水泥固定。调整年龄、性别、种族及相关合并症后,骨水泥固定与 90 天和 1 年复合终点(全因死亡及心肺结局)无关联,与术后第 1 天肌钙蛋白升高亦无统计学显著关联。
要点
- 骨水泥固定与未固定相比,90 天复合终点 OR 1.0(95%CI 0.7-1.4;p=0.99),1 年 OR 1.0(95%CI 0.7-1.4;p=0.95)。
- 骨水泥固定与术后第 1 天肌钙蛋白升高无统计学显著关联(OR 1.4,95%CI 1.0-1.9;p=0.06)。
- 本研究结果进一步支持在髋部骨折的全髋和半髋置换中使用骨水泥股骨固定的推荐。
核心结论
- 在因髋部骨折行关节置换的患者中,骨水泥固定与未固定相比,心肺结局无差异。
- 这些发现进一步支持在髋部骨折的全髋关节置换和半髋关节置换中使用骨水泥股骨固定的推荐。
- 对骨水泥股骨固定经验有限的外科医生应熟悉这些技能。
- 未来研究应评估骨水泥固定存在哪些障碍以及如何减轻这些障碍。
研究设计与样本
- HIP ATTACK 试验的二次分析(post hoc analysis),该试验为随机对照试验,将髋部骨折患者随机分配至加速手术时间组或常规手术时间组。
- 分析限于因股骨颈骨折行全髋关节置换或半髋关节置换的患者;源队列为 1049 例未失访的关节置换患者,排除固定方式未知 2 例、「其他关节置换」6 例及非股骨颈骨折 75 例后,纳入 966 例。
- 966 例中 61%(593 例)接受骨水泥固定;骨水泥固定组年龄中位数(IQR)82(74-88)岁 vs 未固定组 79(71-86)岁(p=0.003)。
- 未固定组接受全髋关节置换(对比半髋)的比例高于骨水泥固定组:24%(91 例)vs 11%(66 例)(p<0.001)。
- 采用逻辑回归估计骨水泥使用与复合结局(全因死亡及多种心肺结局)的关联,检验效能为 80% 以检测 OR≥1.6,并调整两组间除麻醉和手术时长外的所有基线差异。
主要发现
- 调整年龄、性别、种族和相关合并症后,骨水泥使用与 90 天复合结局无关联(OR 1.0,95%CI 0.7-1.4;p=0.99)。
- 骨水泥使用与 1 年复合结局无关联(OR 1.0,95%CI 0.7-1.4;p=0.95)。
- 骨水泥使用与术后第 1 天肌钙蛋白升高无统计学显著关联(OR 1.4,95%CI 1.0-1.9;p=0.06)。
关键数值与推荐
- 复合结局包括全因死亡及可能与骨水泥植入综合征相关的心肺结局;仅有少数患者出现仅非严重结局。
- 骨水泥固定组年龄中位数(IQR)82(74-88)岁 vs 未固定组 79(71-86)岁(p=0.003)。
- 未固定组全髋关节置换比例 24%(91 例)vs 骨水泥固定组 11%(66 例)(p<0.001)。
- 90 天复合结局 OR 1.0(95%CI 0.7-1.4;p=0.99);1 年 OR 1.0(95%CI 0.7-1.4;p=0.95)。
- 术后第 1 天肌钙蛋白升高 OR 1.4(95%CI 1.0-1.9;p=0.06)。
临床怎么用
- 作者结论指出,这些发现进一步支持在髋部骨折的全髋关节置换和半髋关节置换中使用骨水泥股骨固定的推荐。
- 作者认为,对骨水泥股骨固定经验有限的外科医生应熟悉这些技能。
- 作者建议未来研究应评估骨水泥固定存在哪些障碍以及如何减轻这些障碍。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cemented fixation in arthroplasty to treat hip fractures is now widely recommended, but it is not universally used. Some surgeons may feel that the risk of bone cement implantation syndrome and its cardiopulmonary sequalae are too high, in part, because the evidence provides little detail on postoperative myocardial injury and other medical complications after cement use. QUESTIONS/PURPOSES: We aimed to use data from the HIP ATTACK trial (an RCT in which patients with a hip fracture were randomized to accelerated time to surgery versus normal timing of surgery) for a secondary analysis to answer the following questions on arthroplasty for patients with hip fractures: (1) Are patients who undergo cemented hip arthroplasty for hip fractures more likely to experience cardiopulmonary events than patients who undergo uncemented hip arthroplasty? (2) Are patients who undergo cemented hip arthroplasty for hip fractures more likely to experience myocardial injury, identified by elevated troponin levels, than patients who undergo uncemented hip arthroplasty? METHODS: We performed a post hoc analysis of the HIP ATTACK trial for a subset of patients who were treated with THA or hemiarthroplasty for a femoral neck fracture because the trial collected postoperative troponin levels to allow us to identify myocardial injury. The HIP ATTACK trial consisted of 2970 patients. We limited our source cohort to the 1049 patients who underwent hip arthroplasty and were not lost to follow-up (four patients who had undergone arthroplasty were lost to follow-up). We excluded two patients with unknown fixation and six patients with "other arthroplasty." We limited our analysis to femoral neck fractures, which excluded 75 more patients. Of the 966 patients who received hip arthroplasty, 61% (593) had cemented fixation. Patients with cemented fixation were older than patients with cementless fixation (median [IQR] 82 (74 to 88) versus 79 (71 to 86); p = 0.003). Race was self-reported by patients and differed between patients with cemented and cementless fixation. A higher proportion of patients who received cementless fixation had undergone THA (compared with hemiarthroplasty) than patients in the cemented fixation group (24% [91] versus 11% [66]; p < 0.001). We used logistic regression to estimate the association between cement use and a composite outcome consisting of all-cause mortality and various cardiopulmonary outcomes. We included cardiopulmonary outcomes possibly associated with bone cement implantation syndrome; there were only a small number of patients who had only nonsevere outcomes. We had 80% power to detect an OR of ≥ 1.6. We adjusted for all baseline differences between both groups except for anesthesia (as it was not associated with the outcome) and duration of surgery (as it is a function of cement use). RESULTS: After controlling for age, sex, race, and relevant comorbidity, we found that cement use was not associated with differences in the composite outcome at 90 days (OR 1.0 [95% confidence interval (CI) 0.7 to 1.4]; p = 0.99) or 1 year (OR 1.0 [95% CI 0.7 to 1.4]; p = 0.95) or with postoperative elevated troponin (OR 1.4 [95% CI 1.0 to 1.9]; p = 0.06) on Day 1. CONCLUSION: There was no difference in cardiopulmonary outcomes among patients with arthroplasty to treat their hip fracture by fixation method. These findings further support the recommendations to use cemented femoral fixation in THA and hemiarthroplasty for patients with hip fractures. Surgeons with limited experience with cemented femoral fixation should familiarize themselves with these skills. Future studies should assess what barriers to cemented fixation exist and how they can be mitigated. LEVEL OF EVIDENCE: Level III, therapeutic study.
引用
- Righolt CH, Borges FK, Sniderman J, et al. Cemented Fixation in Arthroplasty for Hip Fractures Does Not Increase Cardiopulmonary Complications: A Secondary Analysis of the HIP ATTACK Trial. Clin Orthop Relat Res. 2025. PMID: 40828989. doi:10.1097/CORR.0000000000003645
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。